July 28, 2023
The US Food and Drug Administration (FDA) has approved the second opioid overdose reversal agent for over-the-counter (OTC) nonprescription use. ReVive (Harm Reduction Therapeutics Inc) is […]
July 28, 2023
GE HealthCare is recalling 7559 TruSignal arterial oxygen saturation (SpO2) sensors because of problems that may reduce defibrillation energy, expose patients to unintended voltage, or give […]
July 27, 2023
Abiomed is recalling all Impella left-sided blood pumps in the US over a potential safety issue when used in patients with a transcatheter aortic valve replacement […]
July 27, 2023
The European Commission (EC) on July 25 approved the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin (Jardiance) for treating adults with chronic kidney disease (CKD). The approval for this new […]
July 26, 2023
Abbott is recalling the Amplatzer steerable delivery sheath, used to deliver the Amplatzer Amulet left atrial appendage occluder during cardiac catheterization, because of an increased risk […]
July 21, 2023
The US Food and Drug Administration today approved quizartinib (Vanflyta) for adults with acute myeloid leukemia (AML) that carries the FLT3-ITD genetic mutation. The FDA also […]
July 17, 2023
The US Food and Drug Administration (FDA) on Monday approved a vaccine against respiratory syncytial virus (RSV) for newborns and infants. The monoclonal antibody Beyfortus (nirsevimab-alip), […]
July 11, 2023
The US Food and Drug Administration has cleared the Tandem Mobi insulin pump for people with diabetes aged 6 years or older. The product is half […]
July 11, 2023
The US Food and Drug Administration (FDA) has determined that paclitaxel-delivering stents and balloons for peripheral-artery interventions do not pose an excess mortality risk, the agency […]